INZY
Price:
$4.98
Market Cap:
$312.42M
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2020-07-24
Stock Exchange
NASDAQ
Ticker
INZY
According to Inozyme Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 343.89M. This represents a change of 7.22% compared to the average of 320.74M of the last 4 quarters.
The mean historical Enterprise Value of Inozyme Pharma, Inc. over the last ten years is 167.85M. The current 343.89M Enterprise Value has changed 20.39% with respect to the historical average. Over the past ten years (40 quarters), INZY's Enterprise Value was at its highest in in the March 2024 quarter at 477.57M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
167.85M
Median
229.54M
Minimum
0
Maximum
324.06M
Discovering the peaks and valleys of Inozyme Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Enterprise Value = 324.06M
Minimum Annual Increase = -90.40%
Minimum Annual Enterprise Value = 0
Year | Enterprise Value | Change |
---|---|---|
2023 | 232.84M | 1.62% |
2022 | 13.51M | -90.40% |
2021 | 140.72M | -56.57% |
2020 | 324.06M | 38.32% |
2019 | 234.29M | 2.07% |
2018 | 229.54M | Infinity% |
The current Enterprise Value of Inozyme Pharma, Inc. (INZY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
129.03M
5-year avg
189.08M
10-year avg
167.85M
Inozyme Pharma, Inc.’s Enterprise Value is less than Day One Biopharmaceuticals, Inc. (1.01B), greater than X4 Pharmaceuticals, Inc. (40.79M), greater than Acumen Pharmaceuticals, Inc. (93.64M), less than Mereo BioPharma Group plc (582.99M), less than Terns Pharmaceuticals, Inc. (458.36M), greater than PDS Biotechnology Corporation (74.53M), greater than HOOKIPA Pharma Inc. (87.25M), greater than Eledon Pharmaceuticals, Inc. (75.34M), greater than Amylyx Pharmaceuticals, Inc. (89.50M),
Company | Enterprise Value | Market cap |
---|---|---|
1.01B | $1.25B | |
40.79M | $109.78M | |
93.64M | $133.38M | |
582.99M | $664.26M | |
458.36M | $549.60M | |
74.53M | $107.88M | |
87.25M | $159.50M | |
75.34M | $100.73M | |
89.50M | $161.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inozyme Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Inozyme Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Inozyme Pharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Inozyme Pharma, Inc. (INZY)?
What is the 3-year average Enterprise Value for Inozyme Pharma, Inc. (INZY)?
What is the 5-year average Enterprise Value for Inozyme Pharma, Inc. (INZY)?
How does the current Enterprise Value for Inozyme Pharma, Inc. (INZY) compare to its historical average?